ArticleContemporary oncology (Poznan, Poland)2020

Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients.

Maha Elkammah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.